跳至主要内容
临床试验/NCT03828097
NCT03828097已完成不适用

The Effects of a Multi-vitamin Supplement on Mood and Blood Markers in Adult Females Prior to and Following 12 Weeks of Supplementation

Auburn University2 个研究点 分布在 1 个国家目标入组 94 人开始时间: 2018年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
94
试验地点
2
主要终点
Red blood cell omega-3 and omega-6 concentrations

研究概览

简要总结

The investigators are examining how the daily consumption of a multi-vitamin/mineral supplement affects the following variables in 21-40 year old women:

  1. blood levels of various micronutrients (assessed from blood draws using mass spectrometry-based assays)
  2. blood cell gene expression patterns (assessed from blood draws and real-time PCR assays)
  3. mood (assessed via questionnaires) Blood and questionnaires will be collected prior to supplementation, and 12 weeks into supplementation.

详细描述

The investigators are testing the efficacy of a multi-vitamin/mineral/omega-3 complex on psychological and physiological measures in pre-menopausal women (21-40 years old) over a 12-week period.

This study will be a double-blinded, placebo-controlled intervention. Briefly, subjects will be screened for inclusion criteria. Eligible subjects will then undergo a pre-testing battery (i.e., T1) and will then be randomly assigned to one of two groups including:

  1. Experimental group (anticipated n=50)
  2. Control group (anticipated n=50) Subjects will then consume 2 capsules per day for 12 weeks and perform a post-testing battery (i.e., T2) that includes tests performed during the pre-testing battery.

Main outcome (dependent) variables between treatments will include:

  1. blood levels of various micronutrients (assessed from blood draws using mass spectrometry-based assays)
  2. blood cell gene expression patterns (assessed from blood draws and real-time PCR assays)
  3. mood (assessed via questionnaires) Blood and questionnaires will be collected prior to supplementation, and 12 weeks into supplementation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

盲法说明

Pills are in white bottles with unique ID numbers (1-110). Pills are also flavor-matched (mint).

入排标准

年龄范围
21 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Subjects must be healthy adult women (21-40 years)
  • Subjects must possess a body mass index between 20-30 kg/m2
  • Subjects can be of all demographics, race, and skin types
  • Subjects must have a regular menstrual cycle
  • Subjects must have never have smoked tobacco
  • Subjects must be willing to practice at least one of the following methods of birth control: (1) Total abstinence from sexual intercourse with someone of the opposite sex during the study duration; (2) Sexual intercourse with a vasectomized partner; (3) Contraceptive (oral, parenteral, or transdermal) for at least 3 consecutive months prior to and during the study duration; (4) Use of an intrauterine contraceptive device; (5) Other acceptable forms of birth control (condoms, contraceptive sponge, diaphragm or vaginal ring with spermicidal jellies or cream).
  • Subjects must be able to travel to test site on scheduled dates/times without transportation issues.

排除标准

  • Any prescribed medication except for oral contraceptives (not acceptable if oral contraceptives are used to disrupt normal/monthly menstrual cycle) - includes recent antibiotic and/or oral corticosteroid use
  • Medical history including the following: cardiovascular disease, cancer, coagulopathies, current anemia, epilepsy, thyroid disease, parathyroid diseases, diabetes, hepatitis, brain injuries or other brain-related diseases, depression treated with prescription medications, liver diseases, abnormal lipid metabolism, digestive disorders (Crohn's, pancreatitis, ulcerative colitis), multiple sclerosis, muscular dystrophy, asthma/COPD
  • Anyone incapable of adhering to the study protocol or knowing likelihood of moving away from the study site
  • Known allergies to algal oils, high-oleic sunflower oil, coconuts/coconut oil
  • Pregnant (or become pregnant during the course of the study)
  • Past or active smokers
  • Irregular menstrual cycles or amenorrhea
  • Donated blood within two months prior to study entry, and must not donate blood during the study duration
  • Consumers of alcohol, > 5 drinks of alcohol per week; one drink of alcohol was considered to be 142 mL of standard wine, 340 mL of beer, 35 mL of 80-proof liquor, or 10 mL of pure alcohol
  • Dietary practices: more than one fish meal per week, or daily consumption of more than a Tablespoon of flaxseeds
  • Caffeine-containing beverages are allowable if not excessive (more than the equivalent of 6 cups of coffee daily) and if they do not contain added vitamins; energy drinks or energy capsules containing caffeine are allowable if they have been used routinely
  • Dietary Supplements: those taking multivitamin-mineral (MVM), prenatal vitamins, B vitamins, fish oil, krill oil, flaxseed oil dietary supplements. Meal replacement drinks or powders with 100% or more of the Daily Values for vitamins and minerals are also excluded, but if subjects cease their use they can be admitted into the study.
  • *Allowable supplements include calcium with or without Vitamin D (if the Vitamin D does not exceed 400 IU daily), fiber supplements not exceeding recommended doses on product labels, melatonin, niacin, herbal supplements without added vitamins, glucosamine/chondroitin, sports supplements, drinks or powders that do not contain vitamins and minerals (for example: protein powders, creatine, electrolytes, nitric oxide enhancers). Other supplements can be considered on a case-by-case basis.
  • Study subjects must not be in active litigation regarding malpractice, workman's compensation, or disability claims.
  • Study subjects must not be employees (temporary, part-time, full-time, etc.) or a family member of the research staff conducting the study.

结局指标

主要结局

Red blood cell omega-3 and omega-6 concentrations

时间窗: 12 weeks

Red blood cells will be collected at PRE and POST-intervention and assayed for red blood cell omega-3 and omega-6 fatty acid content. Overall changes in these metabolites will be compared to pre-intervention values to determine if the experimental intervention was more effective at altering these fatty acid levels in red blood cells.

Serum concentrations of micronutrients

时间窗: 12 weeks

Blood serum will be collected at PRE and POST-intervention and assessed for 25-hydroxycholecalciferol (25OHD), and folate as well as 6 associated metabolites \[folic acid, 5-methyltetrahydrofolate (5-MeTHF), 5-formyltetrahydrofolate (5-FoTHF), homocysteine (Hcy), S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH)\]. Overall changes in these metabolites will be compared to pre-intervention values to determine if the experimental intervention was more effective at increasing one or multiple micronutrient levels in serum.

次要结局

  • Blood red blood cell concentrations(12 weeks)
  • White blood cell concentrations(12 weeks)
  • Serum cholesterol concentrations(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Michael Roberts

Associate Professor

Auburn University

研究点 (2)

Loading locations...

相似试验